Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4048-1
Published April 6, 2022 · Recall initiated: February 25, 2022
Summary
FDA records drug Class III recall D-0727-2022, published April 6, 2022 and initiated February 25, 2022. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Reported quantity: 768 tubes; Lot: Lot #: AC33883, Exp. Date June 2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- Product was distributed to one retail consignee in NY.
- Lot
- Lot #: AC33883, Exp. Date June 2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited,April 6, 2022
- FDAGONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS PharmacyApril 6, 2022
- FDA(CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345, APSApril 6, 2022
- FDATESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Packaged in a multi dose 10ML vial, as a)April 6, 2022
- FDACytocell 8 Square Template Slides (Glass)- microscope slides Reference: PCN008March 30, 2022
- FDACompella Therapy Air Supply UnitMarch 30, 2022
Questions about this recall
Was Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4048-1 recalled?
Yes. FDA published recall D-0727-2022 on April 6, 2022. Reported hazard: Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE.